Valuation: Tempus AI, Inc.

Market Cap 15.35B 23,406B 13.5B 12.77B 11.58B 21.75B 1,474B 21.87B 153B 59.04B 752B 57.64B 56.39B 2,416B P/E 2026 *
-61.1x
P/E 2027 * -65.2x
Enterprise Value 15.95B 24,320B 14.03B 13.27B 12.03B 22.6B 1,531B 22.73B 159B 61.34B 781B 59.88B 58.59B 2,511B EV / Sales 2026 *
9.99x
EV / Sales 2027 * 8.05x
Free-Float
61.4%
Yield 2026 *
-
Yield 2027 * -
1 day+0.09%
1 week+10.40%
Current month+37.16%
1 month+34.04%
3 months+59.83%
6 months+119.54%
Current year+49.80%
1 week 10,060
Extreme 10060
11,630
1 month 7,720
Extreme 7720
11,630
Current year 5,165
Extreme 5165
11,630
1 year 5,165
Extreme 5165
13,350
3 years 5,160
Extreme 5160
13,350
5 years 5,160
Extreme 5160
13,350
10 years 5,160
Extreme 5160
13,350
Manager TitleAgeSince
Chief Executive Officer 56 31/07/2015
Director of Finance/CFO 40 31/07/2017
Chief Administrative Officer 55 31/05/2020
Director TitleAgeSince
Chairman 56 31/07/2015
Director/Board Member 53 28/10/2019
Director/Board Member 74 31/08/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.09%+10.40% - - 15.34B
+2.64%+6.45%+11.87%+38.40% 47.97B
+0.22%+0.40%+50.91%+37.06% 44.5B
-1.58%+4.66%+359.34%+614.38% 43.93B
+1.70%+0.36%+12.56%+99.27% 41.03B
+0.51%-1.71%+5.18%+46.87% 29.85B
-0.48%-1.32%+23.98%+150.01% 17.27B
+0.08%+9.03%+8.41% - 15.34B
+1.76%+0.85%+29.13%+48.42% 15.3B
+1.97%-3.17% - - 14.82B
Average +0.69%+1.63%+62.67%+147.77% 30B
Weighted average by Cap. +0.71%+1.89%+79.47%+163.79%

Financials

2026 *2027 *
Net sales 1.6B 2,433B 1.4B 1.33B 1.2B 2.26B 153B 2.27B 15.89B 6.14B 78.18B 5.99B 5.86B 251B 1.97B 3,000B 1.73B 1.64B 1.48B 2.79B 189B 2.8B 19.59B 7.57B 96.37B 7.39B 7.23B 310B
Net income -246M -375B -216M -205M -186M -349M -23.62B -351M -2.45B -946M -12.05B -924M -904M -38.73B -236M -360B -208M -197M -178M -335M -22.69B -337M -2.35B -909M -11.58B -888M -868M -37.21B
Net Debt 599M 913B 527M 498M 452M 849M 57.51B 854M 5.97B 2.3B 29.35B 2.25B 2.2B 94.3B 488M 745B 430M 406M 368M 692M 46.89B 696M 4.86B 1.88B 23.92B 1.83B 1.79B 76.88B
Logo Tempus AI, Inc.
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Employees
3,800
Date Price Change Volume
28/09/26 ARS 11,460.00 +0.09% 16,850
25/09/26 ARS 11,450.00 +3.81% 19,167
24/09/26 ARS 11,030.00 +7.71% 59,688
23/09/26 ARS 10,240.00 -0.10% 1,064
22/09/26 ARS 10,250.00 -1.25% 19,992
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
85.08USD
Average target price
68.56USD
Spread / Average Target
-19.42%

Quarterly revenue - Rate of surprise